Challenges of Diagnosing Viral Anterior Uveitis by Hakan-Groen, F. (Fahriye) et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=ioii20
Download by: [Erasmus University] Date: 06 November 2017, At: 23:49
Ocular Immunology and Inflammation
ISSN: 0927-3948 (Print) 1744-5078 (Online) Journal homepage: http://www.tandfonline.com/loi/ioii20
Challenges of Diagnosing Viral Anterior Uveitis
Fahriye Groen-Hakan, Kalpana Babu, Ilknur Tugal-Tutkun, Kessara
Pathanapithoon, Joke H. de Boer, Justine R. Smith, Jolanda D.F. de Groot-
Mijnes & Aniki Rothova
To cite this article: Fahriye Groen-Hakan, Kalpana Babu, Ilknur Tugal-Tutkun, Kessara
Pathanapithoon, Joke H. de Boer, Justine R. Smith, Jolanda D.F. de Groot-Mijnes & Aniki Rothova
(2017) Challenges of Diagnosing Viral Anterior Uveitis, Ocular Immunology and Inflammation, 25:5,
710-720, DOI: 10.1080/09273948.2017.1353105
To link to this article:  http://dx.doi.org/10.1080/09273948.2017.1353105
Published with license by Taylor & Francis©
Fahriye Groen-Hakan, Kalpana Babu, Ilknur
Tugal-Tutkun, Kessara Pathanapithoon, Joke
H. de Boer, Justine R. Smith, Jolanda D. F. de
Groot-Mijnes, and Aniki Rothova.
Published online: 11 Oct 2017.
Submit your article to this journal 
View related articles 
View Crossmark data
ORIGINAL ARTICLE
Challenges of Diagnosing Viral Anterior Uveitis
Fahriye Groen-Hakan, MD1, Kalpana Babu, MD, PHD2, Ilknur Tugal-Tutkun, MD3, Kessara
Pathanapithoon, MD, PHD4, Joke H. de Boer, MD, PHD5, Justine R. Smith, FRANZCO, PHD6, Jolanda D.F.
de Groot-Mijnes, PHD7, and Aniki Rothova, MD, PHD1
1Department of Ophthalmology, Faculty of Medicine, Erasmus University, Rotterdam, The Netherlands,
2Prabha Eye Clinic & Research Centre, Vittala International Institute of Ophthalmology, Bangalore, India,
3Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey,
4Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand,
5Department of Ophthalmology, Faculty of Medicine, Utrecht University, Utrecht, The Netherlands, 6Eye &
Vision Health, Flinders University School of Medicine, Adelaide, Australia, and 7Department of Medical
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ABSTRACT
The viral causes of anterior uveitis (AU) emerged with the use of novel molecular diagnostic tests and serologic
tests adapted for small volumes (Goldmann-Witmer Coefﬁcient). The viral causes of AU may be underestimated,
and some of the presumed idiopathic AU cases will probably be proven to be of viral origin in the coming years. So
far, a viral origin of AU was suspected in patients who presented with unilateral hypertensive AU. It is not clear
which clinical presentations should raise a suspicion of viral etiology. There is an overlap in the clinical manifesta-
tions of AU caused by viruses and other non-viral forms of AU. A viral cause of AU should be suspected in patients
with unilateral AU, exhibiting small or medium sized KPs, some form of iris atrophy, high IOP and early
development of a cataract and the deﬁnitive diagnosis can be proven by aqueous humor analysis.
Keywords: Anterior Uveitis, Clinical Features, Diagnosis, Viral Uveitis
INTRODUCTION
Anterior uveitis (AU) is the most common anatomic
type of uveitis encountered by ophthalmologists.1
Though traditionally reported that most cases of AU
are of unknown origin, the speciﬁc etiology may pre-
sently be documented in a substantial number of cases.
The AU has multiple causes and in adults, the most
frequent entity is Human Leukocyte Antigen-B27
(HLA-B27)-associated uveitis, whilst juvenile idio-
pathic arthritis (JIA)-associated AU is the most fre-
quent entity occurring in children.1,2 The viral causes
of AU emerged with the use of novel molecular diag-
nostic tests and serologic tests adapted for small
volumes (Goldmann–Witmer Coefﬁcient; GWC). The
viral causes of AU may be underestimated, and some
of the presumed idiopathic AU cases will probably be
proven to be of viral origin in the coming years.
The most common AU-inciting infections and asso-
ciated systemic diseases are given in Tables 1 and 2.
Herpes simplex virus (HSV) and varicella zoster virus
(VZV) represent common viral causes of AU in the
West, whilst cytomegalovirus (CMV) is more frequent
in Asia.1,3,4 In contrast to decreasing prevalence of
rubella virus (RV)-associated AU in vaccinated popu-
lations, novel uveitis entities, such as Ebola virus and
Zika virus-associated uveitis, were discovered during
recent epidemics.5
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So far, a viral origin of AU was suspected in
patients who were presented with unilateral hyperten-
sive AU. Further, distinctive signs were described for
separate viruses, but it is not clear which clinical pre-
sentations should raise a suspicion of viral etiology.
Herein we summarize the typical clinical manifesta-
tions of the common types of AU encountered in clin-
ical practice and attempt to delineate the clinical
characteristics commonly seen in patients with viral
AU.
CLINICAL FEATURES OF COMMON NON-
INFECTIOUS ANTERIOR UVEITIS ENTITIES
Human Leukocyte Antigen-B27-Associated
Anterior Uveitis
Human leukocyte antigen-B27-associated uveitis is
characterized by unilateral alternating acute non-gran-
ulomatous AU with marked ﬁbrinous reaction or
hypopyon Figure 1, occurring typically in young
adults, and has a frequent association with seronega-
tive arthritic syndromes, of which the most prevalent
is ankylosing spondylitis. Patients typically present
with sudden onset of a classic triad of pain, redness,
and photophobia. The main external signs are conjunc-
tival and perilimbal redness. The anterior segment
shows diffuse cells and ﬂare in the anterior chamber;
sometimes with cells adhering to corneal endothelium,
but large keratic precipitates (KPs) are not present.
Intraocular pressure (IOP) often decreases in the
acutely inﬂamed eye, but in severe cases, a ﬁbrinous
exudate and posterior synechiae may occlude the
entire pupil leading to iris bombé and dramatic eleva-
tions in IOP. Less typical presentations involve poster-
ior segment involvement including vitritis with or
without pars plana exudates, optic disc swelling or
papillitis, and cystoid macular edema (CME). Chronic
AU as well as episcleritis and scleritis are less typical.2
Sarcoidosis-Associated Anterior Uveitis
Sarcoidosis may be associated with all anatomical
types of uveitis. Anterior uveitis due to sarcoidosis is
typically seen in young adults, more often in non-
Caucasian races. The patient with sarcoidosis-asso-
ciated AU may present with a few complaints and a
relatively white eye. Raised IOP is often noted.
Sarcoidosis-associated AU shows predominantly bilat-
eral granulomatous inﬂammation with large fatty KPs
located in the inferior part of the cornea (Arlt’s trian-
gle, Figure 2) and has sometimes also characteristic
granulomatous lesions on the iris, such as Koeppe
and/or Busacca nodules. Posterior and anterior syne-
chiae are common in this entity, and may be associated
with the development of glaucoma.6 Cystoid macular
edema is a common complication of sarcoidosis-asso-
ciated AU.7,8 The presence of systemic sarcoidosis in a
patient with uveitis of unknown origin is generally
accepted as a conﬁrmation of sarcoidosis-associated
AU. Ocular signs suggestive of sarcoidosis were
assessed by the initiative to deﬁne clinical criteria for
TABLE 1. Common causes and associations with systemic diseases of patients with anterior uveitis.
Most common Less common
Infectious viral anterior uveitis Herpes simplex virus
Varicella zoster virus
Cytomegalovirus
Rubella virus
Human T-cell lymphotropic virus type 1
Human immunodeﬁciency virus
Chikungunya virus
Zika virus
Ebola virus
Presumed viral causes:
Epstein–Barr virus
Parvovirus
Infectious Bacterial anterior uveitis Bacterial causes:
Treponema pallidum
Mycobacterium tuberculosis
Non-infectious Rheumatologic diseases HLA-B27-associated uveitis
JIA-associated uveitis
Psoriatic arthritis: HLA-B27 positive and negative
Reactive arthritis
Rheumatoid arthritis
Autoimmune systemic diseases TINU syndrome Vogt–Koyanagi–Harada syndrome
Granulomatosis with polyangiitis
Sjögren’s disease
Systemic sclerosis
Autoimmune hepatitis
Autoinﬂammatory systemic diseases Sarcoidosis-associated uveitis Inﬂammatory bowel disease: Ulcerative colitis, Crohns’ disease
Systemic vasculitis: Behcet’s disease
Relapsing polychondritis
HLA-B27 = Human Leukocyte Antigen B27, JIA = Juvenile Idiopathic Arthritis, TINU = Tubulointerstitial Nephritis and Uveitis
Syndrome.
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the diagnosis of intraocular sarcoidosis (International
Workshop on Ocular Sarcoidosis; IWOS).6
Juvenile Idiopathic Arthritis-Associated
Anterior Uveitis
Anterior uveitis is the most common anatomic locali-
zation found in childhood uveitis and is associated
with JIA in approximately 80% of the cases.9
Development of uveitis is most common among
patients with oligoarticular, rheumatoid factor-nega-
tive and psoriatic arthritis subtypes. Antinuclear anti-
bodies (ANAs) are positive in 90% of the patients.10
Clinical features of JIA-associated uveitis include
mostly bilateral non-granulomatous inﬂammation,
anterior in location, insidious at onset with chronic
course. Juvenile idiopathic arthritis-associated AU is
frequently initially asymptomatic. Uveitis in JIA can
worsen over time as a result of many sight-threatening
complications, such as band keratopathy in the visual
axis, posterior synechiae, cataract, secondary glau-
coma, macular edema, hypotony, epiretinal mem-
brane, and optic nerve edema. Different studies have
pointed out that several factors are associated with
poor prognosis, including young age at onset, male
gender, short interval between diagnosis of arthritis
and uveitis, severity of uveitis at onset and ANA
positivity.11–14 Unilateral permanent visual loss at the
age of 18 was observed in 33% of the patients and
bilateral visual loss occurred in 4%.15 Although uveitis
in JIA is considered a disease of childhood, the major-
ity of the patients experience persistent ocular inﬂam-
mation into adulthood.15
Tubulointerstitial Nephritis and Uveitis
Syndrome
Tubulointerstitial nephritis and uveitis (TINU) syn-
drome affects mostly young patients with a peak inci-
dence at the age of 14 years.16 It accounts for 1%–2% of
all uveitis patients in specialized centers, but this num-
ber is probably underestimated since the nephritis
component is often self-limiting and therefore not
recognized.17 Uveitis in TINU syndrome has mostly a
chronic bilateral course and is frequently classiﬁed as
AU in the literature, however vitritis may be
prominent.18,19 Deﬁnitive diagnosis of TINU syn-
drome is based on histopathological examination of
renal tissue. However, renal biopsy is not being per-
formed in mild cases, because of the associated risks.16
Probable TINU syndrome can be diagnosed by abnor-
mal renal function urine analysis and systemic illness
in the presence of uveitis.16 The combination of urin-
ary β-2 microglobulin and serum creatinine is a rela-
tively simple screening tool for renal dysfunction in
order to diagnose probable TINU syndrome in young
patients with uveitis.18
Toxic Uveitis
Past and current medication history may reveal an asso-
ciation of AU with the development of inﬂammatory or
toxic reactions to diverse medications used by various
routes.20–22 Topical prostaglandin analogues may cause
an acute non-granulomatous or chronic granulomatous
AU. Topical brimonidine has been associated with a
chronic AU, characterized by diffusely distributed stel-
late or micro-granulomatous KPs and a mild anterior
chamber reaction, with or without concurrent
conjunctivitis.23 Intravitreal triamcinolone acetonide or
anti-vascular endothelial growth factor (VEGF) injec-
tions may cause a mild AU or a sterile endophthalmitis
with hypopyon inmore severe cases.20 An acute bilateral
hypopyon may develop in immunocompromised
patients who receive rifabutin as prophylaxis against
Mycobacterium avium complex.20,21 Biphosphonates
FIGURE 1. Conjunctival and perilimbal redness with ﬁbrinous
reaction seen in the pupil and hypopyon in patient with HLA-
B27-associated AU
FIGURE 2. Keratic precipitates in sarcoidosis-associated ante-
rior uveitis
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that are used for the treatment of osteoporosis may cause
an acute bilateral nongranulomatous AU with or with-
out scleritis.20–22 Intravenous or intravitreal administra-
tion of cidofovir, an antiviral agent used for the
treatment of CMV retinitis, may cause non-granuloma-
tous AU typically associated with ocular hypotony.20,21
Bacillus Calmette–Guérin (BCG) vaccination or intrave-
sical BCG for the treatment of bladder cancer may rarely
cause an acute bilateral non-granulomatous or granulo-
matous AU.20 Melanoma or metastatic cancer patients
receiving immune checkpoint inhibitors, such as ipilimu-
mab, pembrolizumab, or nivolumab, may present with
red eyes andmild or severe AUwith posterior synechiae
which may also be associated with keratitis.22 Anti-
tumor necrosis factor (TNF) agents, particularly etaner-
cept, may cause a paradoxical intraocular inﬂammation,
which may sometimes present as a sarcoid-like granulo-
matous anterior uveitis.20,21 Bilateral acute iris transillu-
mination (BAIT) syndrome, which can mimic acute
iridocyclitis, has been linked to oral ﬂuoroquinolones,
especially moxiﬂoxacin Figure 3. It is characterized by
severe photophobia associated with bilateral pigment
dispersion into the anterior chamber, diffuse iris trans
illumination, and atonic distorted pupils.24
CLINICAL FEATURES OF COMMON
BACTERIAL ANTERIOR UVEITIS ENTITIES
Syphilis-Associated Anterior Uveitis
Non-granulomatous as well as granulomatous inﬂam-
mationwith iris nodules and posterior synechiae may be
the initial presentations of syphilis. Roseolae located on
the iris represent a known feature in syphilis. Episcleritis,
scleritis, keratitis, and hypopyon were also reported.
Increase in IOP can occur during active inﬂammation.
The diagnosis is usually based on serological tests. The
Centers for Disease Control and Prevention currently
recommends Enzyme Immunosassays (EIAs) and
Chemiluminescent Immunoassays (CIAs) to detect anti-
bodies to treponemal antigens as the best screening tests
for syphilis followed by testing of positive specimens
with the non-treponemal test, rapid plasma regain
(RPR). Specimens positive by EIA and CIA and negative
on RPR are submitted for a conﬁrmatory Treponema
pallidum particle agglutination test and if positive, the
diagnosis of syphilis is conﬁrmed.25,26
Tuberculosis-Associated Anterior Uveitis
Intraocular inﬂammation secondary to tuberculosis (TB)
is common in developing countries. Patients with AU due
to TB present with unilateral or bilateral symptoms of
redness, pain, photophobia, and ﬂoaters. Tuberculosis-
associated AU can be markedly asymmetric. Adjacent
ocular involvement in the form of scleritis, interstitial
keratitis Figure 4, phlycten and chronic conjunctivitis
may also be seen. Anterior uveitis is characterized by
medium to largeKPs Figure 5,which can be fewor diffuse
over the corneal endothelium. Pigmented hypopyon has
also been reported in intraocular TB. Fibrin in anterior
chamber may be seen in aggressive inﬂammation.
Inﬂammation may also be accompanied by Koeppe or
Busacca nodules, or by nodules located in the iridocorneal
FIGURE 4. Interstitial keratitis due to tuberculosis
FIGURE 3. Diffuse iris transillumination and mild dilated dis-
torted pupils in the right (A) and left (B) eye of a 56-year-old
woman who had symptoms of bilateral acute iridocyclitis 1
month after the use of oral moxiﬂoxacin for the treatment of
urinary system infection
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angle Figure 5, which may lead to secondary glaucoma.
Broad-based posterior synechiae may also be seen
Figure 5. Long standing chronic anterior uveitis may be
associated with formation of pupillary membranes and
iris neovascularization. Anterior uveitis may be accompa-
nied by posterior segment involvement like choroiditis,
retinal vasculitis, choroidal tuberculomas, optic nerve
granulomas, and intermediate uveitis. Cataract and glau-
coma are known complications seen in chronic AU.
Conﬁrmation of ocular TB is usually based on indirect
evidence (diagnosis of systemic TB and/or good thera-
peutic response to anti-tuberculous therapy) and tests
based on direct examinations of ocular tissues are less
common. Molecular techniques performed on the intrao-
cular ﬂuids are becoming more widespread, but their
clinical relevance is not yet clearly established).27,28
CLINICAL FEATURES OF COMMON VIRAL
ANTERIOR UVEITIS ENTITIES
Herpes Simplex Virus and Varicella Zoster
Virus-Associated Anterior Uveitis
Herpes simplex virus and VZV, just as CMV belong to
the Herpesviridae family. Following primary infection,
life-long latency is a characteristic feature of this virus
family.29,30 These viruses may present with AU, kera-
titis, dermatitis and/or conjunctivitis.29
Common features of AU due to HSV or VZV infection
are the unilateral localization and acute course commonly
associated with subsequent recurrences or development
of chronicity. Anterior chamber inﬂammation may be
severe, and KPs of diverse types and sizes have been
reported. An irregular pupil is a typical ﬁnding and is
caused by iris atrophy (typically sectoral in HSV or more
diffuse in VZV), which is caused by ischemic necrosis of
iris stroma.31 Intraocular pressure is usually elevated dur-
ing the acute stage and subsequent development of glau-
coma is common.
Associated corneal opacities in herpetic AU are
commonly observed, but corneal involvement may
be entirely absent. Herpes simplex virus-associated
keratitis typically shows stromal inﬂammation with
associated endotheliitis and ﬁne corneal dendrites
without elevated appearance, while VZV-associated
keratitis is interstitial with corneal ring inﬁltrates and
rough dendrites lacking terminal bulbs that can have
an elevated appearance.29,30 Furthermore, patients
with HSV or VZV-associated AU show decreased
corneal sensation.30,32,33 In contrast to HSV, VZV
may show involvement of the vitreous.34 HSV usually
affects children and young adults, VZV is more often
FIGURE 5. Large keratic precipitates with Koeppe nodules on the pupillary margin and broad posterior synechiae in ocular
tuberculosis
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seen in elderly and immunocompromised patients.
Primary infection with HSV is characterized by typi-
cal skin or mucosa lesions. Varicella zoster virus gives
a skin rash with associated vesicles, preceded by pain,
in the ipsilateral dermatome. In cases associated with
uveitis, typically the tip of the nose is also affected
(Hutchinson sign).
Cytomegalovirus-Associated Anterior Uveitis
Cytomegalovirus-associated anterior segment inﬂam-
mation in non-human immunodeﬁciency virus (HIV)-
infected patients has a spectrum of clinical presenta-
tions, including Posner–Schlossmann and Fuchs uvei-
tis syndromes (FUS). Cytomegalovirus-associated AU
may also present as corneal endotheliitis, with corneal
edema ranging from a small localized area to diffuse
bullous keratopathy, associated with mild AU. The
IOP is often acutely or chronically elevated. Keratic
precipitates may be non-granulomatous, granuloma-
tous or stellate, and are usually located in the inferior
half of the cornea. They may be diffuse, linear or show
a ring pattern or may appear as a coin-like lesions.
White, medium-sized, nodular lesions surrounded by
a translucent halo are also possible. Vitritis or retinitis
in these eyes is rare.35,36
Rubella Virus-Associated Anterior Uveitis
Rubella virus-associated AU was reported as one of
the causes of FUS.5,37,38 However, RV-associated AU
does not always fulﬁll the criteria of FUS. Patients with
RV-associated AU are usually young adults at time of
ﬁrst ophthalmological presentation, and at that time
typically have mild uveitis without synechiae, but may
already have a cataract causing visual impairment.
Unilateral involvement, the presence of ﬁne KPs and
diffuse iris atrophy are typical for RV-associated AU.39
Multiple iris nodules, easily visible in brown eyes,
might be overlooked in patients with a light iris. The
absence of redness and pain are typical. Focal “toxo-
plasmosis-like” chorioretinal scars may be seen.34 The
presence of vitritis is frequent, and RV-associated AU
may be mistaken for idiopathic intermediate uveitis.
Human T-Cell Lymphotropic Virus Type 1-
Associated Anterior Uveitis
Southern Japan and Africa are the endemic areas for
human T-cell lymphotropic virus type 1 (HTLV-1)
infection. Major ocular symptoms of HTLV-1-asso-
ciated uveitis are sudden onset of ﬂoaters and blurred
vision, but pain, itching, and foreign body sensation
may also be reported.40–42 On examination, typically
uni- or bilateral mild iritis is seen, frequently
associated with vitritis. Retinal vasculitis may also be
seen.40–42 Graves’ disease is probably a risk factor for
HTLV-1 associated uveitis and HTLV-1 associated
uveitis appears to be related to HTLV-1 induced mye-
lopathy, however these relationships require further
investigation.42,43 In short, HTLV-1 associated uveitis
is most frequently of intermediate type.
Human Immunodeﬁciency Virus-Associated
Anterior Uveitis
Human immunodeﬁciency virus (HIV) causes a multi-
system disease that may also involve the eyes. The
presence of intraocular HIV-1 RNA was shown in
about one-third of HIV-positive patients with infectious
uveitis, but the HIV loads in the eye were typically
lower than in plasma.44 Human immunodeﬁciency
virus-induced uveitis was reported in patients in
whom HIV loads in intraocular ﬂuids exceeded the
plasma loads; these patients are typically highly active,
anti-retroviral therapy (HAART)-naïve and have low
CD4 counts.45,46 Patients with HIV-associated uveitis
complain of decreased vision but pain or conjunctival
hyperemia is characteristically absent. The anatomic
location of uveitis is typically anterior associated with
vitritis and resembles FUS, but is more frequently bilat-
eral. There are no associated retinal lesions or scars, no
ﬁndings suggestive of opportunistic infections, and
patients do not respond to topical corticosteroid ther-
apy. Anterior segment inﬂammation is mild; KPs are
small and/or medium sized, and scattered on the
whole corneal endothelium. After the administration
of HAART, the intraocular inﬂammation disappears
quickly, as the intraocular and plasma HIV loads
decrease. Therefore, HIV-induced uveitis should be
suspected in non-treated HIV-positive patients or in
those in whom such treatment has failed or in HIV-
positive patients who have AU without any retinal
lesions, no proven infectious cause and exhibit no
response to topical corticosteroids.47
Chikungunya Virus-Associated Anterior Uveitis
Non-granulomatous AU may occur after a recent
history of systemic chikungunya virus infection.
Fine- to medium-sized KPs with pigmentation may
be seen distributed all over the endothelium. The
IOP may be increased at the time of active inﬂam-
mation. A FUS pattern may also be seen in chikun-
gunya virus-related AU.48 Accompanying posterior
segment involvement in the form of retinitis is seen
in many cases. Conﬁrmation is by polymerase chain
reaction (PCR) for chikungunya viral RNA.
Treatment is usually with anti-inﬂammatory agents,
like non-steroidal anti-inﬂammatory drugs
(NSAIDS) and topical corticosteroids.48–50
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Zika Virus-Associated Anterior Uveitis
Zika virus disease is a mosquito-borne infection trans-
mitted by the Aedes aegypti mosquito. There are also
reports describing infection following sexual, perinatal,
and blood transfusions. The Zika virus infection was
ﬁrst reported in Uganda, clinically showing a similar
presentation to Dengue virus.51 The disease is mild in
adults with acute infection, and includes anterior uveitis
with non-purulent conjunctivitis. It has a benign prog-
nosis and is treated with topical steroids. In congenital
infections, microcephaly is commonly described, and
ocular ﬁndings include anterior segment abnormalities,
such as iris coloboma and lens subluxation.52,53
Ebola Virus-Associated Anterior Uveitis
Survivors of Ebola virus infection in convalescent
phase suffer a slow and painful recovery with devel-
opment of many complications. Around 20% of survi-
vors of Ebola virus infection develop uveitis (after
recovery of systemic disease), suggesting that the
virus remains viable in the eye.54 It remains unclear
whether Ebola-associated AU is caused by cytopathic
effect of the virus or represents an immune response,
but one-study reports on the detection of Ebola virus
in aqueous humor of a patient with uveitis after the
clearance of viremia.55,56 Anterior uveitis has been
reported, which usually presents with KPs and poster-
ior synechiae. Cataract and ocular hypertension may
also occur in Ebola-associated AU.54 Approximately
40% of eyes become blind according to the World
Health Organization classiﬁcation. There are no
known demographic and physical risk factors for the
development of uveitis in Ebola virus infection survi-
vors, with the exception of higher viral blood load.
Interestingly, optic neuropathy without uveitis was
also reported.57–60
Uncertain Viral Anterior Uveitis Entities
Epstein–Barr virus-associated anterior uveitis
Epstein–Barr-virus (EBV) is also a member of the herpes
virus family. It has repeatedly been reported as a cause of
diverse types of uveitis, but the role of EBV in uveitis is
not entirely clear, since PCR in aqueous ﬂuid can be
positive in EBV-infected patients without uveitis.61–64
Evidence of intraocular EBV antibody synthesis in AU is
scarce.65,66 However, antiviral treatment with valgancy-
clovir of presumed EBV uveitis has been reported to be
beneﬁcial in patients presenting with uveitis and positive
EBV serology. Epstein–Barr-virus-associated AU can be
preceded by a ﬂu-like prodrome and manifest as severe
AU with ﬁbrinous exudate in the acute stage, associated
also with hyperemia and edema of the optic disc.
Parvovirus-associated anterior uveitis
Acute parvovirus B19 infection causes erythema infec-
tiosum or ﬁfth disease in children, sometimes with
polyarthritis. Interestingly, after acute infection,
serum autoantibodies may be measured in these
patients, such as ANAs and rheumatoid factor.67 This
similarity to JIA, in which patients may also have
arthritis accompanied by ANA formation, raises the
suspicion of a link between parvovirus B19 and JIA.
Speciﬁc intraocular antibody production has been
reported in patients with JIA-associated uveitis.68
There is little evidence that parvovirus B19 is a direct
cause of uveitis, however; in rare instances, parvovirus
B19-associated uveitis has been reported.69–71
Parvovirus B19 DNA was detected in aqueous humor
of occasional patients with uveitis, but was also found
in patients with cataract and serous retinal
detachment.70, 72
CLINICAL SYNDROMES IN ANTERIOR
UVEITIS
Fuchs Uveitis Syndrome and Posner–Schlossman
Syndrome
Fuchs uveitis syndrome, which was ﬁrst described
in the medical literature almost 200 years ago, pre-
sents a clinical picture of unilateral chronic AU;
although variations are described, typical features
include small “stellate” KPs diffusely distributed
across the corneal endothelium, low-grade anterior
chamber cell and ﬂare, absence of posterior syne-
chiae, iris atrophy that ultimately results in the
appearance of iris heterochromia, anterior vitreous
cells, and secondary cataract and glaucoma.73
Recently confocal scanning laser ophthalmoscopy
has expanded on these features, including identiﬁ-
cation of dendritiform and stippled KPs by stan-
dard scanning, and of abnormalities in iris
autoﬂuorescence by near-infrared scanning.74,75
Posner–Schlossman syndrome, or glaucomato-cycli-
tic crisis, also was ﬁrst recognized by ophthalmolo-
gists many generations ago, as a unilateral acute
recurrent AU with few KPs, low-grade anterior
chamber cells and ﬂare, and markedly elevated
IOP.76 More recent descriptions have highlighted
the potential for progressive glaucomatous optic
disc and visual ﬁeld changes.77 Almost simulta-
neously, infectious causes now have been assigned
to both FUS and Posner–Schlossman syndrome.
Rubella virus has been recognized as a cause of
FUS, with epidemiological evidence from the
United States showing a decline in incidence since
the introduction of the rubella vaccination and an
increase in the percentage of cases in foreign-born
residents, and detection of RV in aqueous humor by
Challenges of diagnosing 717
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GWC measurement and/or PCR.5,38,39 Separately,
PCR analyses in aqueous humor have identiﬁed
CMV in patients previously diagnosed with
Posner–Schlossman syndrome or FUS.36 It is likely
that other viruses may cause clinical pictures that
suggest one of these syndromes, as exempliﬁed by
the report from India, of a patient with bilateral
FUS, whose aqueous ﬂuid tested positively for
Chikungunya viral, but not RV, DNA by PCR.48
Although it should be noted that concomitant
involvement of RV could not be excluded as
GWC, which has a sensitivity of nearly 100%, com-
pared to 10%–20% for PCR, was not performed.
Immune Recovery Uveitis
Immune recovery uveitis (IRU) may present as an
isolated anterior uveitis or more commonly with con-
current vitritis and CME, following immune recovery
after highly active antiretroviral therapy in HIV
patients or after tapering or discontinuation of immu-
nosuppressive therapy in non-HIV patients with CMV
retinitis. The condition represents an active immune
response to CMV antigens that persist in the eye.78–80
Posterior synechiae and posterior subcapsular cataract
may develop, and after intraocular surgery, the post-
operative course may be complicated by large inﬂam-
matory deposits on the surface of the intraocular
lens.78
LABORATORY DIAGNOSIS OF VIRAL
UVEITIS
For the laboratory diagnosis of viral AU, one may
perform blood analysis. However, serology at the
most excludes a certain virus in the case of a nega-
tive result, or indicates whether a patient has ever
been infected with the particular virus in the case of
a positive result. In addition, most causes of viral
AU have high seroprevalences in most parts of the
world, particularly VZV and RV, rendering serol-
ogy for these causes of little value. Polymerase
chain reaction on peripheral blood is by no means
conclusive, as negative results do not exclude an
intraocular infection, and positive results do not
prove one. A deﬁnitive diagnosis is only obtained
by intraocular ﬂuid analysis. Aqueous humor may
be investigated by PCR or GWC analysis, to deter-
mine intraocular antibody production.37,38,81
Depending on the immune status, time of sam-
pling and type of uveitis (chronic or (sub)acute),
PCR or GWC analysis may be more sensitive.
However, as these data may not always be avail-
able, it is advisable to perform both assays if
possible.82,83
CONCLUSIONS
Viral AU is typiﬁed by unilateral mild AU with ﬁne-
or medium-sized KPs, some form of iris atrophy, and
sometimes high IOP, see Table 2. Cataract and glau-
coma are common complications in viral AU and
presence of vitritis in speciﬁc viral entities is common.
There is an overlap in the clinical manifestations of
AU caused by viruses and other non-viral forms of
AU. Moreover, there is no speciﬁc feature that is
indicative of viral AU, as many signs and symptoms
may vary between speciﬁc viral causes (pain, redness,
synechiae, corneal, and vitreous involvement).
Several viral AU entities may be accompanied by a
prominent vitritis (eg. RV, HTLV, and HIV), which
can be misleading in making of correct diagnosis.
FUS is usually also classiﬁed as AU, however vitreous
involvement in FUS may be severe, and associated
chorioretinal scars and papillitis also have been
reported. It might be more correct to classify patients
according to their actual presentations as intermedi-
ate or panuveitis.
In conclusion, a viral cause of AU should be sus-
pected in patients with unilateral AU, exhibiting
small- or medium-sized KPs, some form of iris atro-
phy, high IOP, and early development of a cataract.
Whilst medical history, serologic results and clinical
features might raise a suspicion of viral etiology, the
deﬁnitive diagnosis can be proven by aqueous humor
analysis.
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